Skip to main content
NCBI home page
Clinical Molecular Pathology logoLink to Clinical Molecular Pathology
. 1995 Feb;48(1):M51–M54. doi: 10.1136/mp.48.1.m51

Neurological disease associated with Mycoplasma pneumoniae infection. PCR evidence against a direct invasive mechanism

C G Fink 1,2,3,4,5, M Sillis 1,2,3,4,5, S J Read 1,2,3,4,5, L Butler 1,2,3,4,5, M Pike 1,2,3,4,5
PMCID: PMC407920  PMID: 16695976

Abstract

Aims—To investigate the pathology in patients presenting with sudden onset neurological illnesses associated with Mycoplasma pneumoniae infection.

Methods—M pneumoniae infection was diagnosed by a highly rigorous interpretation of serological markers initially using complement fixation, agglutination and IgM antibodies. Confirmation of the serological diagnosis was achieved using indirect immunofluorescence for IgM, IgA, and IgG. Serum and cerebrospinal fluid (CSF) samples from these patients were examined using the polymerase chain reaction to look for evidence of M pneumoniae DNA.

Results—No M pneumoniae DNA was found in any serum or CSF samples. Diagnosis of M pneumoniae infection by agglutination and complement fixation antibodies was not always confirmed by indirect immunofluorescence.

Conclusion—The neurological lesions in these patients do not appear to be caused by the direct invasion of M pneumoniae into the nervous system. The lesions may be an immune response to infection. Serological diagnosis of M pneumoniae continues to be a laboratory problem.

Keywords: Mycoplasma pneumoniae

Keywords: PCR

Keywords: neurological lesions

Keywords: pathogenesis

Full text

PDF
M51

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Biberfeld G. Antibodies to brain and other tissues in cases of Mycoplasma pneumoniae infection. Clin Exp Immunol. 1971 Feb;8(2):319–333. [PMC free article] [PubMed] [Google Scholar]
  2. Fernandez C. V., Bortolussi R., Gordon K., Lee S. H., Gatien J. G., Shahdrabadi M. S. Mycoplasma pneumoniae infection associated with central nervous system complications. J Child Neurol. 1993 Jan;8(1):27–31. doi: 10.1177/088307389300800104. [DOI] [PubMed] [Google Scholar]
  3. Fink C. G., Butler L. A cranial nerve palsy associated with Mycoplasma pneumoniae infection. Polymerase chain reaction evidence against an infectious mechanism. Br J Ophthalmol. 1993 Nov;77(11):750–751. doi: 10.1136/bjo.77.11.750. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Fleischhauer P., Hüben U., Mertens H., Sethi K. K., Thürmann D. Nachweis von Mycoplasma pneumoniae im Liquor bei akuter Polyneuritis. Dtsch Med Wochenschr. 1972 Apr 28;97(17):678–682. doi: 10.1055/s-0028-1107421. [DOI] [PubMed] [Google Scholar]
  5. Gnarpe J., Lundbäck A., Sundelöf B., Gnarpe H. Prevalence of Mycoplasma pneumoniae in subjectively healthy individuals. Scand J Infect Dis. 1992;24(2):161–164. doi: 10.3109/00365549209052607. [DOI] [PubMed] [Google Scholar]
  6. Koletsky R. J., Weinstein A. J. Fulminant Mycoplasma pneumoniae infection. Report of a fatal case, and a review of the literature. Am Rev Respir Dis. 1980 Sep;122(3):491–496. doi: 10.1164/arrd.1980.122.3.491. [DOI] [PubMed] [Google Scholar]
  7. Koskiniemi M. CNS manifestations associated with Mycoplasma pneumoniae infections: summary of cases at the University of Helsinki and review. Clin Infect Dis. 1993 Aug;17 (Suppl 1):S52–S57. doi: 10.1093/clinids/17.Supplement_1.S52. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Lyell A., Gordon A. M., Dick H. M., Sommerville R. G. Mycoplasmas and erythema multiforme. Lancet. 1967 Nov 25;2(7526):1116–1118. doi: 10.1016/s0140-6736(67)90620-4. [DOI] [PubMed] [Google Scholar]
  9. Meseguer M. A., de Rafael L., Vidal M. L. Stevens-Johnson syndrome with isolation of Mycoplasma pneumoniae from skin lesions. Eur J Clin Microbiol. 1986 Apr;5(2):167–168. doi: 10.1007/BF02013977. [DOI] [PubMed] [Google Scholar]
  10. Murray H. W., Masur H., Senterfit L. B., Roberts R. B. The protean manifestations of Mycoplasma pneumoniae infection in adults. Am J Med. 1975 Feb;58(2):229–242. doi: 10.1016/0002-9343(75)90574-4. [DOI] [PubMed] [Google Scholar]
  11. Shames J. M., George R. B., Holliday W. B., Rasch J. R., Mogabgab W. J. Comparison of antibiotics in the treatment of mycoplasmal pneumonia. Arch Intern Med. 1970 Apr;125(4):680–684. [PubMed] [Google Scholar]
  12. Sillis M. The limitations of IgM assays in the serological diagnosis of Mycoplasma pneumoniae infections. J Med Microbiol. 1990 Dec;33(4):253–258. doi: 10.1099/00222615-33-4-253. [DOI] [PubMed] [Google Scholar]
  13. Smith C. B., McGinniss M. H., Schmidt P. J. Changes in erythrocyte I agglutinogen and anti-I-agglutinins during Mycoplasma pneumoniae infection in man. J Immunol. 1967 Aug;99(2):333–339. [PubMed] [Google Scholar]
  14. Thomas N. H., Collins J. E., Robb S. A., Robinson R. O. Mycoplasma pneumoniae infection and neurological disease. Arch Dis Child. 1993 Nov;69(5):573–576. doi: 10.1136/adc.69.5.573. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical Molecular Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES